TIDMKMK TIDMAMP

RNS Number : 2618E

Kromek Group PLC

07 April 2014

For immediate release: 7 April 2014

Kromek Group plc ("Kromek" or "the Company")

Director / PDMR shareholding

The Company was informed today that Richard Morgan, Chairman of the Company, purchased 40,000 Ordinary Shares ("Shares") of 1p each at an average of 50p per share on 07 April 2014, representing 0.04 per cent of the Company's total issued share capital.

Mr Morgan's total holding in the Company is now 372,310 Shares of 1p each, representing 0.35 per cent of the Company's total issued share capital.

Mr Morgan is also interested in Amphion Innovations plc through his Directorship in Amphion Innovations plc which holds 12,450,420 ordinary shares in Kromek being 11.6 per cent of the Company's total issued share capital.

-ends-

For further information, please contact:

 
 Kromek Group plc                         Tel: 01740 626060 
  Arnab Basu, CEO 
  Derek Bulmer, CFO 
 Panmure Gordon                           Tel: 020 7886 2500 
  As Nominated Adviser and Broker 
  Corporate Finance 
  Freddy Crossley 
  Broking 
  Adam Pollock/ Charles Leigh-Pemberton 
 Tavistock Communications                 Tel: 020 7920 3150 
  Matt Ridsdale / Andrew Dunn

About Kromek Group plc

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

Kromek uses multiple technologies in its manufacturing processes, including the established methods of 'liquid phase' detector production, and also 'vapour phase' production methods, which allow the production of high quality, high performance detectors on an industrial scale. Kromek has an intellectual property portfolio of more than 70 granted patents and 110 pending applications.

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Board believes that the vertical integration offered by Kromek, combined with the benefit of 25 years of research into CZT production and the patents and trade secrets accumulated by the Group, are unparalleled in the market place.

The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over a hundred full time employees across its global operations.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKODPPBKDFQK

Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Amphion Innovations Charts.
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Amphion Innovations Charts.